Abernethy’s Departure From US FDA Gives Next Commissioner Options For A New Number Two

 
• By Kate Rawson
  
THE QUESTION OF WHO WILL BE THE US FDA’S NUMBER TWO IS STARTING TO LOOM ALMOST AS LARGE AS WHO WILL BE THE COMMISSIONER.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership